3021 POSTER Association between exposure to bevacizumab (BV) beyond first progression (BBP) and overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): results from a large observational study (BRiTE)

✍ Scribed by A. Grothey; M. Sugrue; E. Hedrick; D. Purdie; P. Chiruvolu; W. Dong; D. Sargent; M. Kozloff

• Book ID: 118625791
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 76 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70949-7